These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12165807

  • 1. The effectors of killer activity induced by interferon-alpha and gamma in peripheral blood mononuclear cells.
    Sakaguchi M, Kubota S, Nishikido M, Taniguchi K, Inuzuka S, Saito Y, Kanetake H, Koga S.
    Int J Mol Med; 2002 Sep; 10(3):317-20. PubMed ID: 12165807
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H, Zhou FJ, Wang QJ, Qin ZK, Huang LX, Liu ZW, Han H, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [Abstract] [Full Text] [Related]

  • 3. Type-I interferon receptor expression: its circadian rhythm and downregulation after interferon-alpha administration in peripheral blood cells from renal cancer patients.
    Shiba M, Nonomura N, Nakai Y, Nakayama M, Takayama H, Inoue H, Tsujimura A, Nishimura K, Okuyama A.
    Int J Urol; 2009 Apr; 16(4):356-9. PubMed ID: 19302507
    [Abstract] [Full Text] [Related]

  • 4. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
    Gigante M, Mandic M, Wesa AK, Cavalcanti E, Dambrosio M, Mancini V, Battaglia M, Gesualdo L, Storkus WJ, Ranieri E.
    J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
    [Abstract] [Full Text] [Related]

  • 5. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
    Chochi K, Ichikura T, Majima T, Kawabata T, Matsumoto A, Sugasawa H, Kawarabayashi N, Takayama E, Hiraide H, Seki S, Mochizuki H.
    Oncol Rep; 2003 Apr; 10(5):1443-8. PubMed ID: 12883721
    [Abstract] [Full Text] [Related]

  • 6. [Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma].
    Tsunoda T, Tanimura H, Yamaue H, Tani M, Iwahashi M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun 20; 25(6):1110-8. PubMed ID: 2118938
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma.
    Koga S, Nishikido M, Matsuya F, Kanetake H, Saito Y.
    Anticancer Res; 1999 Jun 20; 19(6C):5547-50. PubMed ID: 10697614
    [Abstract] [Full Text] [Related]

  • 8. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.
    J Immunol; 2009 Nov 15; 183(10):6612-8. PubMed ID: 19846870
    [Abstract] [Full Text] [Related]

  • 9. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N, Ono M, Kodama M, Yamanaka Y, Hirakata H, Hirano D, Fuse T, Takimoto Y.
    Hinyokika Kiyo; 1995 Jan 15; 41(1):21-6. PubMed ID: 7900565
    [Abstract] [Full Text] [Related]

  • 10. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells.
    Motegi A, Kinoshita M, Sato K, Shinomiya N, Ono S, Nonoyama S, Hiraide H, Seki S.
    J Leukoc Biol; 2006 Mar 15; 79(3):463-72. PubMed ID: 16387840
    [Abstract] [Full Text] [Related]

  • 11. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K, Tsukamoto T.
    Hinyokika Kiyo; 1989 May 15; 35(5):737-47. PubMed ID: 2801371
    [Abstract] [Full Text] [Related]

  • 12. Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.
    Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Noguchi K, Arii K, Hotta T.
    Nihon Geka Hokan; 1991 Nov 01; 60(6):396-405. PubMed ID: 1820012
    [Abstract] [Full Text] [Related]

  • 13. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
    Fujimiya Y, Wagner RJ, Groveman S, Sielaff K, Kohsaka T, Nakayama M.
    Ther Immunol; 1995 Feb 01; 2(1):15-22. PubMed ID: 7553067
    [Abstract] [Full Text] [Related]

  • 14. Effects of interferon-alpha and gamma on development of LAK activity from mononuclear cells in breast cancer patients.
    Kamamura Y, Takahashi K, Komaki K, Monden Y.
    J Med Invest; 1998 Aug 01; 45(1-4):71-5. PubMed ID: 9864966
    [Abstract] [Full Text] [Related]

  • 15. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
    Liberati AM, Schippa M, Portuesi MG, Grazia Proietti M, De Angelis V, Ferrajoli A, Cinieri S, Di Clemente F, Palmisano L, Berruto P.
    Haematologica; 1991 Aug 01; 76(5):375-82. PubMed ID: 1806440
    [Abstract] [Full Text] [Related]

  • 16. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
    Shi M, Zhang B, Tang ZR, Lei ZY, Wang HF, Feng YY, Liu JC, Fan ZP, Li HW, Mu JS, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2049-53. PubMed ID: 14703414
    [Abstract] [Full Text] [Related]

  • 17. [Modulation of the rate of CD158a+/b+ cells by Th1-and Th2-like cytokines].
    Pan XH, Guo KY, Song JG, Li JQ, Pang RQ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan 10; 19(1):56-8. PubMed ID: 15132908
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T, Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ichikawa T, Ueda T, Nikaido T, Ito H, Ishikura H.
    Cancer; 2005 Jan 15; 103(2):258-67. PubMed ID: 15578685
    [Abstract] [Full Text] [Related]

  • 19. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro.
    Kosonen J, Luhtala M, Viander M, Kalimo K, Terho EO, Savolainen J.
    Exp Dermatol; 2005 Jul 15; 14(7):551-8. PubMed ID: 15946244
    [Abstract] [Full Text] [Related]

  • 20. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY, Yang BY, Wu CY.
    Cell Biol Int; 2008 Feb 15; 32(2):188-97. PubMed ID: 17920947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.